182 related articles for article (PubMed ID: 11300025)
21. [New insights into the combinability of Eloxation (oxaliplatin): present and future prospects].
Longo F
Tumori; 2003; 89(1):A1-2. PubMed ID: 12729376
[No Abstract] [Full Text] [Related]
22. [Oxaliplatin].
Bascioni R
Suppl Tumori; 2004; 3(4):S111-2. PubMed ID: 15206232
[No Abstract] [Full Text] [Related]
23. Review of oxaliplatin: an active platinum agent in colorectal cancer.
Cassidy J
Int J Clin Pract; 2000; 54(6):399-402. PubMed ID: 11092115
[TBL] [Abstract][Full Text] [Related]
24. Sequencing therapies: the role of targeted agents in metastatic colorectal cancer.
Oestreicher P
ONS Connect; 2007; 22(8 Suppl):37-8. PubMed ID: 17824557
[No Abstract] [Full Text] [Related]
25. Oxaliplatin. A platinum compound for colorectal cancer?
Balzer KM
Cancer Pract; 2000; 8(4):201-3. PubMed ID: 11898261
[No Abstract] [Full Text] [Related]
26. Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study.
Suenaga M; Mizunuma N; Matsusaka S; Shinozaki E; Ozaka M; Ogura M; Yamaguchi T
Drug Des Devel Ther; 2015; 9():3099-108. PubMed ID: 26124634
[TBL] [Abstract][Full Text] [Related]
27. An increasingly common challenge: management of the complete responder with multi-focal metastatic colorectal cancer.
Schrag D; Weiser M; Schattner M; Shia J; Akhurst T
J Clin Oncol; 2005 Mar; 23(9):1799-802. PubMed ID: 15774773
[No Abstract] [Full Text] [Related]
28. Should FOLFOXIRI plus bevacizumab Be the standard first-line therapy in metastatic colorectal cancer?
Nipp RD; Ryan DP
Oncologist; 2015 Mar; 20(3):236-8. PubMed ID: 25660156
[TBL] [Abstract][Full Text] [Related]
29. [Oxaliplatin: combinations with thymidylate synthetase inhibitors: two consecutive phase II studies].
Martoni A; Mini E; Pinto C; Gentile A; Mazzei T
Tumori; 2001; 87(6):A25-6. PubMed ID: 11995701
[No Abstract] [Full Text] [Related]
30. Oxaliplatin: a review of approved uses.
Stein A; Arnold D
Expert Opin Pharmacother; 2012 Jan; 13(1):125-37. PubMed ID: 22149372
[TBL] [Abstract][Full Text] [Related]
31. The use cetuximab after oxaliplatin-based chemotherapy in a patient with metastatic colorectal cancer.
Malik Z; Eng C
Clin Adv Hematol Oncol; 2007 Jan; 5(1 Suppl 1):4-7. PubMed ID: 17491584
[No Abstract] [Full Text] [Related]
32. Oxaliplatin: a new therapeutic option in colorectal cancer.
Cvitkovic E; Bekradda M
Semin Oncol; 1999 Dec; 26(6):647-62. PubMed ID: 10606258
[TBL] [Abstract][Full Text] [Related]
33. Combination chemotherapy and colorectal cancer.
Sumpter K; Cunningham D
Semin Oncol; 2000 Oct; 27(5 Suppl 10):105-11. PubMed ID: 11049041
[No Abstract] [Full Text] [Related]
34. Chemotherapy of metastatic colorectal cancer: fluorouracil plus folinic acid and irinotecan or oxaliplatin.
Prescrire Int; 2005 Dec; 14(80):230-3. PubMed ID: 16400749
[TBL] [Abstract][Full Text] [Related]
35. Current treatment options for advanced colorectal cancer.
Rougier P; Mitry E
Semin Oncol; 2000 Oct; 27(5 Suppl 10):30-3. PubMed ID: 11049030
[No Abstract] [Full Text] [Related]
36. [Oxaliplatin: perspectives and future developments].
Marty M; Cottu PH; Lerebours F; Bedairia N; Hocini H; Espié M
Bull Cancer; 2001 Aug; 88 Spec No():S5-8. PubMed ID: 11567907
[No Abstract] [Full Text] [Related]
37. Prediction of survival by neutropenia according to delivery schedule of oxaliplatin-5-Fluorouracil-leucovorin for metastatic colorectal cancer in a randomized international trial (EORTC 05963).
Innominato PF; Giacchetti S; Moreau T; Smaaland R; Focan C; Bjarnason GA; Garufi C; Iacobelli S; Tampellini M; Tumolo S; Carvalho C; Karaboué A; Lévi F;
Chronobiol Int; 2011 Aug; 28(7):586-600. PubMed ID: 21859417
[TBL] [Abstract][Full Text] [Related]
38. [Colorectal carcinoma--approval of eloxatine in adjuvant therapy--better chances for recovery].
Krankenpfl J; 2004; 42(7-10):234. PubMed ID: 15675396
[No Abstract] [Full Text] [Related]
39. FOLFOXIRI in metastatic colorectal cancer: A criticism from its native land.
Ottaiano A; Nasti G; Cassata A; De Stefano A; Caraglia M; Avallone A
Cancer Lett; 2017 Nov; 408():71-72. PubMed ID: 28844712
[No Abstract] [Full Text] [Related]
40. Oxaliplatin: available data in non-colorectal gastrointestinal malignancies.
Bécouarn Y; Agostini C; Trufflandier N; Boulanger V
Crit Rev Oncol Hematol; 2001 Dec; 40(3):265-72. PubMed ID: 11738949
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
